Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Changing infant mortality: the need to spend more while getting less.

B S Bloom

    Pediatrics
    |June 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Laser-assisted drug delivery: beyond ablative devices.

    The British journal of dermatology·2014
    Same author

    Breast cancer treatment in clinical practice compared to best evidence and practice guidelines.

    British journal of cancer·2004
    Same author

    Sale of prescription drugs over the Internet.

    LDI issue brief·2003
    Same author

    What is this nonsense that complementary and alternative medicine is not amenable to controlled investigation of population effects?

    Academic medicine : journal of the Association of American Medical Colleges·2001
    Same author

    Daily regimen and compliance with treatment.

    BMJ (Clinical research ed.)·2001
    Same author

    What do we know about gastroesophageal reflux disease?

    The American journal of gastroenterology·2001
    Same journal

    Video vs Telephone Consultations for Pediatric Quality of Care in Emergency Departments.

    Pediatrics·2026
    Same journal

    A Resource to Understand and Prevent Sudden Unexpected Infant Deaths.

    Pediatrics·2026
    Same journal

    Influenza Vaccine Effectiveness Against Pediatric Death in the United States: 2016-2025.

    Pediatrics·2026
    Same journal

    Averting the Unthinkable: Immunization to Prevent Childhood Deaths From Influenza.

    Pediatrics·2026
    Same journal

    Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

    Pediatrics·2026
    Same journal

    Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

    Pediatrics·2026
    See all related articles

    Infant and maternal mortality have declined significantly due to public health advances, not solely medical care. Further reductions via high-tech medical interventions may escalate costs, posing societal funding challenges.

    Area of Science:

    • Public Health
    • Medical Economics
    • Healthcare Policy

    Background:

    • Historical declines in infant and maternal mortality are largely attributed to improvements in infectious disease control, social, economic, and public health measures.
    • Significant medical care interventions have had a limited impact on mortality reductions historically.
    • Current infant mortality rates in high-income countries are low, suggesting diminishing returns from further technological interventions.

    Purpose of the Study:

    • To examine the potential benefits of advanced medical technology for further reducing infant and maternal mortality.
    • To analyze the economic implications and societal willingness to fund high-cost medical interventions for marginal mortality gains.
    • To explore funding sources for advanced medical technologies to ensure equitable access for all expectant mothers and newborns.

    Related Experiment Videos

    Main Methods:

    • This study is a review and analysis of existing data on infant and maternal mortality trends.
    • It synthesizes evidence on the impact of medical technology on mortality rates.
    • It discusses economic principles related to healthcare expenditure and resource allocation.

    Main Results:

    • While medical technology offers potential benefits, its application for marginal reductions in already low infant mortality rates is associated with escalating healthcare expenditures.
    • The cost-effectiveness of high-technology interventions requires careful consideration against societal willingness to pay.
    • Significant funding challenges exist to ensure universal access to costly new and existing medical technologies.

    Conclusions:

    • Further reductions in infant and maternal mortality using advanced medical technology present a cost-benefit dilemma for society.
    • Balancing the pursuit of optimal health outcomes with escalating healthcare costs necessitates strategic policy decisions.
    • Innovative funding models and resource allocation strategies are crucial for equitable access to beneficial medical technologies.